BlackRock Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-9,522
| Closed | -$929K | – | 2974 |
|
|
2015
Q1 | $929K | Buy |
9,522
+5,188
| +120% | +$506K | ﹤0.01% | 1899 |
|
|
2014
Q4 | $402K | Buy |
4,334
+259
| +6% | +$24K | ﹤0.01% | 2304 |
|
|
2014
Q3 | $281K | Sell |
4,075
-74
| -2% | -$5.1K | ﹤0.01% | 2344 |
|
|
2014
Q2 | $435K | Sell |
4,149
-4,622
| -53% | -$485K | ﹤0.01% | 2229 |
|
|
2014
Q1 | $727K | Sell |
8,771
-30,216
| -78% | -$2.5M | ﹤0.01% | 2092 |
|
|
2013
Q4 | $2.52M | Buy |
38,987
+2,909
| +8% | +$188K | ﹤0.01% | 1361 |
|
|
2013
Q3 | $2.29M | Sell |
36,078
-26,300
| -42% | -$1.67M | ﹤0.01% | 1391 |
|
|
2013
Q2 | $2.62M | Buy |
+62,378
| New | +$2.62M | ﹤0.01% | 1178 |
|